Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LMB-2 / National Cancer Institute
NCT00321555: LMB-2 to Treat Hairy Cell Leukemia	Completed	2	15	US	Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin	National Cancer Institute (NCI)	Hairy Cell Leukemia	08/16	12/22
NCT00924170: Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia	Completed	1/2	18	US	LMB-2, Fludarabine, Fludara, Cyclophosphamide, Cytoxan	National Cancer Institute (NCI)	Adult T-Cell Leukemia (ATL)	01/16	05/21